16D0 Dicker, Adam P. - Thomas Jefferson University - Thomas Jefferson University
axd121

Adam P. Dicker, MD, PhD, FASTRO

Contact Dr. Dicker

111 South 11th Street
Room G-301, Bodine Center
Philadelphia, PA 19107

(215) 955-6700
(215) 503-0013 fax

Most Recent Peer-reviewed Publications

  1. Reply to C.G. Rusthoven et al
  2. Evaluating the clinical impact of a genomic classifier in prostate cancer using individualized decision analysis
  3. Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapy
  4. Radiation therapy after radical prostatectomy for prostate cancer: Evaluation of complications and influence of radiation timing on outcomes in a large, population-based cohort
  5. Novel actions of next-generation taxanes benefit advanced stages of prostate cancer
  6. American society of clinical oncology policy statement update: The critical role of phase I trials in cancer research and treatment
  7. Current Clinical Trials Testing Combinations of Immunotherapy and Radiation
  8. Assessing adverse events of postprostatectomy radiation therapy for prostate cancer: Evaluation of outcomes in the regione Emilia-Romagna, Italy
  9. Is robotic arm stereotactic body radiation therapy 'virtual high-dose rate brachytherapy' effective for prostate cancer? An analysis of comparative effectiveness using published data
  10. African-American race is a predictor of seminal vesicle invasion after radical prostatectomy
  11. Characterization of 1577 Primary Prostate Cancers Reveals Novel Biological and Clinicopathologic Insights into Molecular Subtypes
  12. Adjuvant versus salvage radiation therapy for prostate cancer patients with adverse pathologic features: Comparative analysis of long-term outcomes
  13. Quantifying unnecessary normal tissue complication risks due to suboptimal planning: A secondary study of RTOG 0126
  14. African American men with low-grade prostate cancer have increased disease recurrence after prostatectomy compared with Caucasian men
  15. A tissue biomarker -based model that identi fies patients with a high risk of distant metastasis and differential survival by length of androgen deprivation therapy in RTOG protocol 92-02
  16. Adjuvant radiation for node-positive disease after prostatectomy: More good news, but who will listen?
  17. Radiation protection of the gastrointestinal tract and growth inhibition of prostate cancer xenografts by a single compound
  18. The retinoblastoma tumor suppressor modulates DNA repair and radioresponsiveness
  19. AAPM and GEC-ESTRO guidelines for image-guided robotic brachytherapy: Report of Task Group 192
  20. Genomic prostate cancer classifier predicts biochemical failure and metastases in patients after postoperative radiation therapy
0